PBS biosimilar substitution warning


Pharmacists reminded of biosimilar substitution requirements  Pharmacists are being advised to pay attention when selecting Pharmaceutical Benefits Scheme (PBS) codes when substituting biosimilar medications, to ensure the correct product is claimed.   The PBS issued a reminder notice stating that a number of pharmacies “have been receiving a warning reason code 162/163 when substituting [a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Chemist Warehouse – Australia’s new ‘millionaire factory’
Next ‘Medication without harm is a goal we all share’